Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 87
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Clin Infect Dis ; 73(12): 2265-2275, 2021 12 16.
Artículo en Inglés | MEDLINE | ID: mdl-33460434

RESUMEN

BACKGROUND: Benefits of school reopening must be weighed against the morbidity and mortality risks and the impact of enhancing spread of coronavirus disease 2019 (COVID-19). We investigated the effects of school reopening and easing of social-distancing restrictions on dynamics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in Israel between March and July 2020. METHODS: We examined the nationwide age-wise weekly incidence, prevalence, SARS-CoV-2 polymerase chain reaction tests, their positivity, COVID-19 hospitalizations, and associated mortality. Temporal differences in these parameters following school reopening, school ending, and following easing of restrictions such as permission of large-scale gatherings were examined. RESULTS: Incidence of SARS-CoV-2 infections gradually increased following school reopening in all age groups, with a significantly higher increase in adults than children. Higher rate ratios (RRs) of sample positivity rates 21-27 days following school reopening relative to positivity rates prior to openings were found for the age groups 40-59 (RR, 4.72; 95% CI, 3.26-6.83) and 20-39 (RR, 3.37 [2.51-4.53]) years, but not for children aged 0-9 (RR, 1.46 [.85-2.51]) and 10-19 (RR, .93 [.65-1.34]) years. No increase was observed in COVID-19-associated hospitalizations and deaths following school reopening. In contrast, permission of large-scale gatherings was accompanied by increases in incidence and positivity rates of samples for all age groups, and increased hospitalizations and mortality. CONCLUSIONS: This analysis does not support a major role of school reopening in the resurgence of COVID-19 in Israel. Easing restrictions on large-scale gatherings was the major influence on this resurgence.


Asunto(s)
COVID-19 , SARS-CoV-2 , Niño , Preescolar , Humanos , Israel/epidemiología , Instituciones Académicas
2.
Childs Nerv Syst ; 36(2): 411-416, 2020 02.
Artículo en Inglés | MEDLINE | ID: mdl-31292758

RESUMEN

PURPOSE: Cerebral palsy is the most common physical disability in childhood. Our aim was to study the prevalence of wheelchair-dependent cerebral palsy (equivalent to gross motor function classification system level IV/V) among Jewish and Arab children in Israel and to investigate differences between the children of the two population groups. METHODS: Children diagnosed with cerebral palsy born in the years 2005-2006 were located through the Israel National Insurance Institute database. Demographic and clinical data were retrieved from children's records. RESULTS: Overall prevalence in Israel was 0.8 (0.7-0.9) per 1000 live births. The prevalence was significantly higher among Arabs (1.2:1000) than Jews (0.6:1000; OR = 1.6, 95% CI 1.2-2.1, p = 0.001) and was highest among Arabs in the South (Bedouins) (2.8:1000). Consanguinity among parents and low socioeconomic status were significantly more common among Arab children with wheelchair- dependent cerebral palsy compared with Jews. Higher rates of children with cerebral palsy following term pregnancy were found in Arabs. Extreme preterm births, very low birth weight, and emergent cesarean section were more common among Jews compared with Arabs. CONCLUSIONS: This study revealed population group differences of cerebral palsy with Gross Motor Function Classification System levels IV and V. Higher rates of cerebral palsy, especially following term pregnancy in the Arab population, may be attributed to consanguinity and genetic factors. There is a need to tailor services to underserved population based on etiology: preterm births and genetic causes for the Jewish and Arab populations, respectively.


Asunto(s)
Parálisis Cerebral , Comparación Transcultural , Parálisis Cerebral/epidemiología , Cesárea , Niño , Femenino , Humanos , Lactante , Recién Nacido , Israel/epidemiología , Masculino , Embarazo , Prevalencia
3.
J Obstet Gynaecol ; 39(1): 41-48, 2019 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-30244627

RESUMEN

This study sought to evaluate the associations between background exposures and psychological determinants, among postpartum Jewish and Arab women, relative to actual prenatal test endorsement. The independent and aggregative effects of contextual features and the subjective opinions and attitudes relative to a prenatal testing were evaluated, using logistic regressions. After accounting for contextual features, Jews with positive vs. negative opinions on screening were significantly more likely to undergo a prenatal screening. Specifically, having more favourable ideas on pregnancy termination, among Jews, was associated with a greater likelihood of triple test, nuchal translucency and ultrasound uptake as compared with those that refused. Similarly, Arabs who were more inclined to abort the pregnancy had a greater chance of using nuchal translucency and ultrasound vs. those that declined testing. As the preferences for prenatal test outcomes are multifaceted and vary according to population group, a better understanding of the factors involved in making testing choices could help ease the decision-making process. Impact Statement What is already known on this subject? The choice to undergo prenatal screening tests is influenced by various determinants, which include: social, demographic and emotional factors that vary by cultural preferences. Indeed, women integrate (subjective) beliefs and values that extend beyond rational (objective) reasoning when estimating whether or not to undergo testing. It may then be that, prenatal test choices might be, influenced less by actual risk status and more so by emotional factors. And while, the latter are more likely to be amendable, and thus influence changes in perception, the effect of psychological exposures on the decision making process in the genetic testing context, especially among Israeli Jews and Arabs, has been understudied. What the results of this study add? The current study extends the focus by addressing the role of evaluative beliefs and emotional factors involved with formulating prenatal screening judgments relative to actual testing among individuals with diverse profiles (Israeli Jews and Arabs). What was clarified was that background factors and psychological perceptions, such as having supportive attitudes on screening and a willingness to undergo abortion were, for the most part, related to prenatal test uptake. Concomitantly, these involve dense decision-making practices that can be difficult to approximate, as cultural settings and individual preferences often have an impact on intention-to-test. What the implications are of these findings for clinical practice and/or further research? Culturally appropriate counselling that would account for personal preferences alongside actual risk appraisals could enable pregnant women to make informed and autonomous prenatal testing choices. The integration of socio-demographics, psychological correlates and other contextual factors into a theoretical framework, studied uniquely by sub-populations, could enrich future research. Such research can, in turn, provide a clearer picture of the social need for genetic counselling, help customise local interventions, and on a broader scale inform national policy.


Asunto(s)
Toma de Decisiones , Conocimientos, Actitudes y Práctica en Salud , Diagnóstico Prenatal/psicología , Aborto Inducido/psicología , Adulto , Árabes/psicología , Árabes/estadística & datos numéricos , Asistencia Sanitaria Culturalmente Competente , Femenino , Pruebas Genéticas/estadística & datos numéricos , Humanos , Israel , Judíos/psicología , Judíos/estadística & datos numéricos , Periodo Posparto/psicología , Embarazo , Diagnóstico Prenatal/estadística & datos numéricos , Estudios Retrospectivos
4.
Harefuah ; 158(6): 352-356, 2019 Jun.
Artículo en Hebreo | MEDLINE | ID: mdl-31215185

RESUMEN

BACKGROUND: Stroke is a leading cause of death and disability worldwide. Due to the high burden caused by stroke, the Israeli Ministry of Health initiated a national program for the treatment and prevention of stroke, including the establishment of an Israeli National Stroke Registry (INSR). In this article we will demonstrate the use of the INSR as a tool for monitoring the treatment of acute cerebrovascular events (stroke or transient ischemic attack). OBJECTIVES: 1. Assessing incidence rates of acute cerebrovascular events in Israel for the total population and by gender and ethnic group separately. 2. Presenting trends in a number of key indicators related to acute stroke care. METHODS: The INSR is based on data retrieval from hospital electronic medical records of all adult cases discharged with acute cerebrovascular diagnosis from January 1, 2014 on. Included in the current analysis were all cases reported to the INSR until June 31, 2017. RESULTS: The average annual incidence rate of cerebrovascular events in Israel was 3.2 cases per 1,000 people. Age-adjusted rates were significantly higher among Arabs, compared with the Jewish population. From 2014 to 2017 there was a moderate increase in the percentage of arrival by ambulance: from 43.2% to 49.0% and a significant increase in the percentage of head and neck vascular imaging performed: from 50.0% to 72.5%. Between 2014 and 2016 there was a significant increase in the percentage of t-PA administration, and in 2016-2017 the rates stabilized at 9.2%. The proportion of patients hospitalized in neurological wards was 38.0% - a slight increase from 35.0% in 2014. CONCLUSIONS: The INSR is an effective tool for monitoring morbidity and acute stroke care in Israel. Actions should be taken in order to raise public awareness of stroke warning signs and the establishment of stroke units with skilled multidisciplinary teams should become a priority. DISCUSSION: Compared with other western countries, rates of t-PA administration and arrival by ambulance in Israel are slightly low, rates of hospitalization in the neurological ward are significantly lower, and the lack of stroke units is most prominent.


Asunto(s)
Ataque Isquémico Transitorio , Sistema de Registros , Accidente Cerebrovascular , Adulto , Humanos , Israel/epidemiología , Factores de Riesgo , Accidente Cerebrovascular/complicaciones , Accidente Cerebrovascular/epidemiología , Accidente Cerebrovascular/terapia
5.
Clin Infect Dis ; 66(9): 1383-1391, 2018 04 17.
Artículo en Inglés | MEDLINE | ID: mdl-29145568

RESUMEN

Background: The 2016-2017 influenza season in Israel was dominated by the circulation of influenza A(H3N2). Influenza vaccine is recommended for the entire population in Israel aged >6 months. The inactivated influenza vaccine was chosen for use this season. Methods: We estimated the 2016-2017 end-of-season influenza vaccine effectiveness (VE) in preventing influenza-like illness due to influenza A(H3N2), using the test-negative design. Age-specific VE was estimated using a moving age window and weekly analysis. Results: During the 2016-2017 season, 1267 samples were collected; 467 (36.9%) were positive for influenza, with 97.9% A(H3N2), 0.2% A(H1N1)pdm09, and 1.9% B. A total of 1088 individuals were found eligible to be included in VE assessment. All vaccinated individuals included in the VE assessment received the inactivated influenza vaccine. Adjusted VE against influenza A(H3N2) was 29.0% (95% confidence interval [CI], 0.3%-49.5%). Age group-specific adjusted VE was 69.2% (95% CI, 19.4%-88.3%) for children aged 5-17 years and 58.8% (95% CI, .8%-82.9%) for adults aged 45-64 years. Other age groups demonstrated lower VE estimates that were not statistically significant. Adjusted VE estimates using a moving window of 15 years and weekly VE analyses provided a more defined understanding of age-specific VE during the 2016-2017 season. Conclusions: Estimating VE using a moving age window as well as weekly VE analysis may provide more detailed information regarding the relationship between VE and age.


Asunto(s)
Vacunas contra la Influenza/uso terapéutico , Gripe Humana/prevención & control , Vacunación/estadística & datos numéricos , Potencia de la Vacuna , Adolescente , Adulto , Anciano , Estudios de Casos y Controles , Niño , Preescolar , Técnicas de Laboratorio Clínico , Femenino , Humanos , Lactante , Virus de la Influenza A , Virus de la Influenza B , Gripe Humana/epidemiología , Israel/epidemiología , Masculino , Persona de Mediana Edad , Atención Primaria de Salud , Estaciones del Año , Vigilancia de Guardia , Adulto Joven
6.
J Pediatr Hematol Oncol ; 40(8): e525-e530, 2018 11.
Artículo en Inglés | MEDLINE | ID: mdl-29742617

RESUMEN

BACKGROUND: Patients with end-stage renal disease who undergo chronic renal replacement therapy (RRT) have a higher incidence of cancer. A limited number of studies addressed the risk for cancer in children exposed to RRT. The purpose of the present study was to examine whether children undergoing RRT in Israel are at increased risk for all-site and specific cancers. SUBJECTS AND METHODS: The study population comprised 674 children 0 to 19 years of age who were registered between January 1990 and December 2012 in the Israel National Renal Replacement Therapy Registry. The Registry database was linked with the Israel National Cancer Registry to trace cancer incidence. Variables associated with malignancy were estimated by univariate analysis. Standardized incidence ratios for cancer were calculated using the general Israel population 0 to 15 years of age, for the corresponding years 1990-2012, as a reference. RESULTS: Seventeen children developed cancer during the follow-up period. Younger age at RRT initiation was the only variable associated with malignancy in the univariate analysis (hazard ratio, 0.91; 95% confidence interval, 0.84-0.99; P=0.03). Cancer incidence was 6.7-fold higher among children undergoing RRT than the general population. CONCLUSIONS: Children treated by chronic RRT have a higher incidence of cancer than their peers, and therefore should be followed closely.


Asunto(s)
Fallo Renal Crónico/epidemiología , Neoplasias/epidemiología , Sistema de Registros , Terapia de Reemplazo Renal/efectos adversos , Adolescente , Niño , Preescolar , Femenino , Estudios de Seguimiento , Humanos , Incidencia , Lactante , Recién Nacido , Israel/epidemiología , Fallo Renal Crónico/terapia , Masculino , Neoplasias/etiología , Factores de Riesgo
7.
Euro Surveill ; 23(7)2018 02.
Artículo en Inglés | MEDLINE | ID: mdl-29471622

RESUMEN

IntroductionInfluenza vaccine is recommended for the entire population in Israel. We assessed influenza vaccine effectiveness (VE) for the 2014/15 and 2015/16 seasons in Israel, for the first time. Methods: Combined nose and throat swab specimens were collected from patients with influenza-like illness (ILI) presenting to sentinel primary care clinics and tested for influenza virus by RT-PCR. VE of the trivalent inactivated vaccine (TIV) was assessed using test-negative case-control design. Results: During the 2014/15 season 1,142 samples were collected; 327 (28.6%) were positive for influenza, 83.8% A(H3N2), 5.8% A(H1N1)pdm09, 9.2% B and 1.2% A un-subtyped. Adjusted VE against all influenza viruses for this influenza season was -4.8% (95% confidence interval (CI): -54.8 to 29.0) and against influenza A(H3N2), it was -15.8% (95% CI: -72.8 to 22.4). For the 2015/16 season, 1,919 samples were collected; 853 (44.4%) were positive for influenza, 43.5% A(H1N1)pdm09, 57% B, 0.7% A(H3N2) and 11 samples positive for both A(H1N1)pdm09 and B. Adjusted VE against all influenza viruses for this influenza season was 8.8% (95% CI: -25.1 to 33.5), against influenza A(H1N1)pdm09, it was 32.3% (95% CI: (-4.3 to 56.1) and against influenza B, it was -2.2% (95% CI: (-47.0 to 29.0). Conclusions: Using samples from patients with ILI visiting sentinel clinics in Israel, we demonstrated the feasibility of influenza VE estimation in Israel.


Asunto(s)
Subtipo H1N1 del Virus de la Influenza A/inmunología , Subtipo H3N2 del Virus de la Influenza A/inmunología , Vacunas contra la Influenza/administración & dosificación , Gripe Humana/prevención & control , Gripe Humana/virología , Vigilancia de Guardia , Vacunación/estadística & datos numéricos , Potencia de la Vacuna , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Estudios de Casos y Controles , Niño , Preescolar , Femenino , Humanos , Lactante , Subtipo H1N1 del Virus de la Influenza A/aislamiento & purificación , Subtipo H3N2 del Virus de la Influenza A/aislamiento & purificación , Vacunas contra la Influenza/inmunología , Gripe Humana/epidemiología , Israel/epidemiología , Masculino , Persona de Mediana Edad , Atención Primaria de Salud , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Estaciones del Año
8.
Cardiovasc Diabetol ; 16(1): 105, 2017 08 15.
Artículo en Inglés | MEDLINE | ID: mdl-28810857

RESUMEN

BACKGROUND: Diabetes has been reported to be associated with an increased relative risk for mortality, with estimates ranging from 1.1 to 2.1. Findings are inconsistent regarding modification of the risk by gender and by age. The aim of this study was to estimate the mortality risk associated with new-onset diabetes in adulthood, by age group and gender. METHODS: From the database of a large health care provider, we identified 31,987 individuals diagnosed with diabetes during 2003-2005; and 162,656 individuals without diabetes, group-matched by age. We used Cox regression to calculate hazard ratios (HRs) and 95% confidence intervals (95% CIs) for overall mortality adjusted for age, gender, socioeconomic (SE) level, obesity, smoking and comorbidities at baseline. RESULTS: During a median follow-up of 9.5 years, 4464 (14%) of persons with diabetes and 13,327 (8.2%) of those without died. Among persons with incident diabetes, the proportion of men, smokers, obese and patients of low SE level was higher, as was the prevalence of cardiovascular disease and renal impairment at baseline. Incident diabetes was associated with an adjusted HR for mortality of 1.38 (95% CI 1.32-1.43). Mortality HR for DM was comparable with hypertension (1.42; 1.37-1.46), smoking (1.65; 1.58-1.71) and atherosclerosis (1.40; 1.35-1.46). Diabetes associated mortality HR was somewhat higher among women 1.78 (95% CI 1.58-2.08) as compared with men 1.51 (95% CI 1.41-1.62). CONCLUSIONS: Incident diabetes in adults is associated with a substantial risk for mortality, especially in younger adults. Further efforts should be allocated to diabetes primary prevention.


Asunto(s)
Diabetes Mellitus/diagnóstico , Diabetes Mellitus/mortalidad , Vigilancia de la Población , Factores de Edad , Anciano , Enfermedades Cardiovasculares/diagnóstico , Enfermedades Cardiovasculares/mortalidad , Estudios de Cohortes , Femenino , Estudios de Seguimiento , Humanos , Hipertensión/diagnóstico , Hipertensión/mortalidad , Masculino , Persona de Mediana Edad , Mortalidad/tendencias , Obesidad/diagnóstico , Obesidad/mortalidad , Sistema de Registros , Factores de Riesgo , Factores de Tiempo
9.
Qual Life Res ; 26(12): 3343-3352, 2017 12.
Artículo en Inglés | MEDLINE | ID: mdl-28791563

RESUMEN

PURPOSE: Higher health-related quality of life (HRQOL) in dialysis patients has been associated with fewer hospitalizations and lower mortality. Since Arab patients on dialysis have better survival rates than Jewish patients, we hypothesized that they would have higher HRQOL. We also studied the impact of several risk factors on HRQOL in each population. METHODS: Based on a national dialysis registry, patients from 64 hemodialysis units were recruited to participate. Patients who consented were interviewed face-to-face, using the Kidney Disease Quality of Life Short Form (KDQOL-SF36) questionnaire. RESULTS: Five hundred and fifty-eight (50.6%) Jewish and 544 (49.4%) Arab patients participated in the study. For Arab patients mean crude scores for the "mental component summary" and KDQOL scores were significantly lower than for Jewish patients [31.6 (95% Cl 30.0-33.3) vs. 38.0 (95% Cl 36.1-39.9), p < 0.0001 and 55.6 (95% Cl 54.5-56.7) vs. 59.8 (95% Cl 58.6-60.9), p < 0.0001, respectively]. Much lower scores were observed for Arabs in the "emotional role" and "work status" subscales. The two populations had similar general health assessments and albumin level. For both, HRQOL was positively associated with higher educational level, higher albumin level, and dialysis connection by fistula or graft; and negatively associated with low income and diabetes. HRQOL was negatively associated with previous cerebrovascular accident among Arabs and with female gender among Jews. CONCLUSIONS: Differences between Jews and Arabs in subscales related to psychosocial factors suggest that cultural differences in the perceptions of sickness and health may be relevant here. Future studies should explore such possibility and focus on the large gap in the "work status" subscale.


Asunto(s)
Fallo Renal Crónico/terapia , Calidad de Vida/psicología , Diálisis Renal/psicología , Anciano , Árabes , Estudios Transversales , Femenino , Humanos , Judíos , Masculino , Persona de Mediana Edad , Diálisis Renal/métodos , Diálisis Renal/mortalidad , Encuestas y Cuestionarios , Análisis de Supervivencia
10.
Prev Chronic Dis ; 14: E64, 2017 08 10.
Artículo en Inglés | MEDLINE | ID: mdl-28796598

RESUMEN

INTRODUCTION: Chronic diseases constitute a major public health challenge. The prevalence of multiple chronic conditions (MCC) has increased. The objective of our study was to describe the prevalence, correlates, and time trends of MCC in the Israeli population and among the nation's 2 main population groups (Jewish and Arab). METHODS: To describe the prevalence of correlates of MCC, we used data from the 2014-2015 Israeli National Health Interview Survey-III (INHIS-III). MCC was defined as having 2 or more of the following 10 self-reported physician-diagnosed chronic conditions: asthma, arthritis, cancer, diabetes, dyslipidemia, heart attack, hypertension, migraine, osteoporosis, or thyroid disease. For trend analysis, we used data from INHIS-I (2003-2004) and INHIS-II (2007-2010). Logistic regression was used for multivariate analysis. Estimates were weighted to the 2014 Israeli population. P for trend was calculated by using the Cochran-Armitage test for proportions. RESULTS: In 2014-2015, the prevalence of MCC was 27.3% (95% confidence interval, 25.7%-28.8%). In multivariate analysis, MCC was associated with older age, female sex, a monthly household income of USD$3,000 or less, current and past smoking, and overweight or obesity. After adjusting for age, sex, income, smoking status, and body mass index, differences in MCC between Jewish and Arab populations disappeared. Dyslipidemia and hypertension were the most prevalent dyad among both men and women. Dyslipidemia, hypertension, and diabetes were the most prevalent triad among both men and women. The age-adjusted prevalence of MCC increased by 6.7% between 2003-2004 and 2014-2015. CONCLUSION: With the increase in the prevalence of MCC, a comprehensive approach is needed to reduce the burden of chronic conditions. Of special concern are the groups most prone to MCC.


Asunto(s)
Enfermedad Crónica/epidemiología , Encuestas Epidemiológicas , Adolescente , Adulto , Envejecimiento , Niño , Preescolar , Etnicidad , Femenino , Humanos , Israel/epidemiología , Israel/etnología , Modelos Logísticos , Masculino , Persona de Mediana Edad , Prevalencia , Factores de Riesgo , Factores Socioeconómicos , Factores de Tiempo , Adulto Joven
11.
Clin Endocrinol (Oxf) ; 85(5): 813-818, 2016 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-27292870

RESUMEN

CONTEXT: The inconclusive evidence regarding long-term safety of recombinant human growth hormone (rhGH) therapy underlines the need for long-term large-scale cohorts. OBJECTIVE: To assess long-term mortality and cancer incidence among patients treated with rhGH during childhood in Israel. DESIGN: A population-based cohort study. SETTING: Data were retrieved from a national register established in 1988. Mortality data from the national population register were available through 31 December 2014. Data on cancer incidence from the national cancer registry were available through 31 December 2012. PARTICIPANTS: All patients ≤19 years approved for rhGH treatment during 1988-2009 were included. Patients were assigned to three risk categories, according to the underlying condition leading to growth disorder. MAIN OUTCOME MEASURES: All-cause mortality and cancer incidence rates were calculated, based on person-years at risk. Standardized mortality ratios (SMRs) and standardized incidence ratios (SIRs) were calculated, using the Israeli general population as a reference. RESULTS: Included were 1687 patients assigned to the low-risk category and 440 patients assigned to the intermediate-risk category. In the low-risk category, all-cause mortality and cancer incidence were not significantly different than expected (SMR 0·81, 95% CI 0·22-2·08 and SIR 0·76, 95% CI 0·09-2·73). In the intermediate-risk category, all-cause mortality and cancer incidence were significantly higher than expected (SMR 4·05, 95% CI 1·62-8·34 and SIR 4·52, 95% CI 1·22-11·57). CONCLUSIONS: No increased risk of mortality or cancer incidence was found in low-risk patients treated with rhGH during childhood. Patients with prior risk factors were at higher risk of both mortality and cancer.


Asunto(s)
Hormona de Crecimiento Humana/efectos adversos , Neoplasias/inducido químicamente , Edad de Inicio , Preescolar , Estudios de Cohortes , Femenino , Hormona de Crecimiento Humana/uso terapéutico , Humanos , Incidencia , Israel , Masculino , Mortalidad , Neoplasias/epidemiología , Neoplasias/mortalidad , Proteínas Recombinantes , Sistema de Registros , Medición de Riesgo
12.
Soc Psychiatry Psychiatr Epidemiol ; 51(1): 115-23, 2016 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-26364837

RESUMEN

PURPOSE: Official suicide statistics often produce an inaccurate view of suicide populations, since some deaths endorsed as being of uncertain manner are in fact suicides; it is common, therefore, in suicide research, to account for these deaths. We aimed to test the hypothesis that non-suicide death categories contain a large potential reservoir of misclassified suicides. METHODS: Data on undetermined intent and ill-defined death causes, and official suicide deaths recorded in the district of Tel Aviv for the years 2005 and 2008 were extracted. Based on supplementary data, cases regarded as probable suicides ("suicide probable") were then compared with official suicides ("suicide verdicts") on a number of socio-demographic variables, and also in relation to the mechanism of death. RESULTS: Suicide rates were 42 % higher than those officially reported after accounting for 75 probable suicides (erroneously certified under other cause-of-death categories). Both death classifications ("suicide probable" and "suicide verdicts") had many similarities, significantly differing only with respect to method used. Logistic regression confirmed that the most powerful discriminator was whether the mechanism of death was considered "less active" or "more active" (p < 0.001). Indeed, deaths among the less active group were 4.9 times as likely to be classified as "suicide probable" than were deaths among the more active group. CONCLUSIONS: Caution is needed when interpreting local area data on suicide rates, and undetermined and ill-defined deaths should be included in suicide research after excluding cases unlikely to be suicides. Improving suicide case ascertainment, using multiple sources of information, and uniform reporting practices, is advised.


Asunto(s)
Causas de Muerte , Mortalidad , Suicidio/estadística & datos numéricos , Adolescente , Adulto , Anciano , Femenino , Humanos , Israel/epidemiología , Masculino , Persona de Mediana Edad , Adulto Joven
13.
Emerg Infect Dis ; 21(4): 692-4, 2015 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-25811302

RESUMEN

We investigated prevalence of hepatitis E virus in a sample of the population of Israel. The overall seroprevalence of antibodies to the virus was 10.6% (95% CI 8.4%-13.0%); age-adjusted prevalence was 7.6%. Seropositivity was associated with age, Arab ethnicity, low socioeconomic status, and birth in Africa, Asia, or the former Soviet Union.


Asunto(s)
Anticuerpos Antihepatitis/inmunología , Virus de la Hepatitis E/inmunología , Hepatitis E/epidemiología , Hepatitis E/inmunología , Adolescente , Adulto , Anciano , Femenino , Genotipo , Hepatitis E/historia , Hepatitis E/transmisión , Virus de la Hepatitis E/genética , Historia del Siglo XXI , Humanos , Inmunoglobulina G/sangre , Inmunoglobulina G/inmunología , Inmunoglobulina M/sangre , Inmunoglobulina M/inmunología , Israel/epidemiología , Masculino , Persona de Mediana Edad , Oportunidad Relativa , Prevalencia , Estudios Seroepidemiológicos , Adulto Joven
14.
Am J Hum Biol ; 27(1): 94-8, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25156400

RESUMEN

OBJECTIVES: To describe the trend in the rate of consanguineous marriages among the Israeli Arab population and to identify factors associated with this custom shift in recent years. METHODS: The study was conducted between November 2009 and January 2010 in Family Health Centers. A questionnaire was presented to parents during routine visits to the center with their children. RESULTS: Information on 6,437 couples was collected. The rate of consanguineous marriages decreased from 35.8% among those married before 2000, to 28.2% among those married in 2000-2004, and to 24.0% among those married in 2005-2009 (P for trend <0.001). First cousin marriages were the most common type of consanguineous marriages in all the time periods. Consanguineous marriages were associated with consanguinity between the couples' parents (both husband and wife), a high consanguinity rate in the place of residence and younger age at marriage (wife). CONCLUSIONS: The rates of consanguineous marriages among Israeli Arabs are decreasing but still high. Because consanguineous marriages are widely acceptable, the role of public health professionals and primary care personnel is to provide comprehensive information about the potential genetic risks of consanguinity on offspring health and to increase the accessibility of premarital and preconception counseling services.


Asunto(s)
Consanguinidad , Matrimonio , Adolescente , Adulto , Árabes , Femenino , Humanos , Israel , Masculino , Matrimonio/estadística & datos numéricos , Matrimonio/tendencias , Encuestas y Cuestionarios , Adulto Joven
15.
Ann Rheum Dis ; 73(4): 704-9, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-23505237

RESUMEN

OBJECTIVE: There are limited data on long-term comorbidities and mortality among patients with familial Mediterranean fever (FMF). Our objective was to evaluate comorbidities and death rates among individuals with FMF. METHODS: We studied a nationwide, population-based, retrospective cohort of 1225 individuals with FMF (59% men) in a database of 1 244 350 adolescents (16-20 years of age) medically evaluated for military service between 1973 and 1997. This cohort was linked with the national mortality, cancer and end-stage renal disease (ESRD) registries in Israel. Study outcomes were all-cause mortality, occurrence of ESRD and malignancy by the age of 50 years. RESULTS: During 30 years of follow-up, death rates were 8.73/10(4) versus 4.32/10(4) person-years in the FMF and control groups, respectively (p=0.002). In a multivariable analysis adjusted for age, birth year, socio-economic status, education, ethnicity and body mass index, FMF was associated with increased mortality in men (HR=1.705 (95% CI 1.059 to 2.745), p=0.028) and women (HR=2.48 (1.032 to 5.992), p=0.042). Renal amyloidosis accounted for 35% and 60% of deaths in men and women, respectively. FMF was not associated with an increased incidence of cancer. CONCLUSIONS: FMF is associated with increased all-cause mortality that is likely attributed to reduced colchicine compliance or responsiveness. Individuals with FMF do not have an increased incidence of cancer. These results support the awareness among medical community to decrease the higher than average mortality rate among participants with FMF.


Asunto(s)
Fiebre Mediterránea Familiar/mortalidad , Adolescente , Amiloidosis/etiología , Amiloidosis/mortalidad , Estudios de Cohortes , Comorbilidad , Fiebre Mediterránea Familiar/complicaciones , Femenino , Humanos , Incidencia , Israel/epidemiología , Estimación de Kaplan-Meier , Enfermedades Renales/etiología , Enfermedades Renales/mortalidad , Fallo Renal Crónico/etiología , Fallo Renal Crónico/mortalidad , Masculino , Neoplasias/epidemiología , Neoplasias/etiología , Factores de Riesgo , Clase Social , Adulto Joven
16.
Pediatr Diabetes ; 15(6): 422-7, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-24283719

RESUMEN

OBJECTIVE: To assess the trends in the incidence of type 1 diabetes between 1997 and 2010 among 0-17-yr-old Israeli Jews and Arabs compared with global trends. METHODS: Data on children with newly diagnosed type 1 diabetes reported by pediatric endocrinologists from 19 medical centers to the Israel Center for Disease Control, as part of the National Diabetes Register. RESULTS: During 1997-2010, 2857 Jews and 757 Arabs were diagnosed with type 1 diabetes. The average age-adjusted incidence among Jews was higher than Arabs [12.2 per 100 000, 95% confidence interval (CI) 10.5-14.2 and 8.9 per 100 000, 95% CI 7.5-10.7, p = 0.0001, respectively], however, the annual percent change was higher for Arabs compared with Jews (4.0 vs. 3.6%, p = 0.005, respectively). The mean age at diagnosis was similar for Jews and Arabs (9.6 ± 4.4 vs. 9.9 ± 4.4 yr, p = 0.08), and it remained stable during 1997-2010 in both ethnic groups (p = 0.6). In both Jews and Arabs the highest annual percent change was observed in younger children. It was 4.9% for children aged 5-9 yr and 10.7% for children aged 0-4 yr, respectively. There were no differences in the frequency of diabetic ketoacidosis (DKA) between Jews (39.9%) and Arabs (41.3%), (p = 0.5). CONCLUSION: Type 1 diabetes incidence of Jews and Arabs in Israel is increasing. The incidence is higher in Jews than in Arabs; however, the annual percent change is higher in Arabs than in Jews. In both Ethnic groups the incidence of type 1 diabetes is increasing especially among young children.


Asunto(s)
Árabes/estadística & datos numéricos , Diabetes Mellitus Tipo 1/epidemiología , Judíos/estadística & datos numéricos , Adolescente , Niño , Preescolar , Femenino , Humanos , Incidencia , Lactante , Recién Nacido , Israel/epidemiología , Masculino , Sistema de Registros
17.
Harefuah ; 153(3-4): 188-91, 238, 237, 2014.
Artículo en Hebreo | MEDLINE | ID: mdl-24791563

RESUMEN

Syndromic surveillance systems which were developed as part of bioterrorism preparedness initiatives originally focused on early detection. However, the early detection capabilities of such systems proved to be limited, particularly for small-scale outbreaks. On the other hand, syndromic surveillance systems proved to be very effective in situational awareness and in supporting decision making. Today, syndromic surveillance is being implemented in public health practice as a routine tool, working in concert with the traditional surveillance systems.


Asunto(s)
Planificación en Desastres/métodos , Vigilancia de la Población/métodos , Práctica de Salud Pública , Bioterrorismo/prevención & control , Toma de Decisiones , Brotes de Enfermedades/prevención & control , Humanos , Salud Pública
18.
Pediatr Res ; 73(1): 111-9, 2013 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-23085818

RESUMEN

BACKGROUND: A vitamin B(1)-deficient soy-based infant formula was marketed in Israel in 2003, exposing infants to clinical or subclinical B(1) deficiency. We investigated whether subclinical B(1) deficiency in early infancy had medical, neurodevelopmental, or cognitive effects at 3-5 y of age. METHODS: A historical prospective cohort study was conducted consisting of four groups: "exposed," consuming a B(1)-deficient soy-based formula exclusively for four consecutive weeks or longer; "control," consuming no soy-based formula; "mixed," consuming the formula nonexclusively or exclusively for less than four consecutive weeks; and "other," consuming soy-based formulas other than Remedia. Participants were evaluated by medical examination, Stanford-Binet (SB) intelligence test, sensory profile evaluation, and Conners scales (attention deficit disorder/attention deficit and hyperactivity disorder (ADD/ADHD)). RESULTS: Following adjustment for gender, age, and maternal education, there were no significant differences among the four groups on the mean SB scores, on the verbal and nonverbal scores, or in the proportion of children in each group with scores <90. A significantly higher proportion of exposed children as compared with control children had an impaired sensory profile and scores on the Conners scales (ADD/ADHD), but these proportions were also high in the "other" and "mixed" groups. CONCLUSION: The results do not support an association between subclinical B(1) deficiency in infancy and long-term development.


Asunto(s)
Trastorno por Déficit de Atención con Hiperactividad/etiología , Desarrollo Infantil/fisiología , Fórmulas Infantiles/química , Deficiencia de Tiamina/complicaciones , Deficiencia de Tiamina/patología , Factores de Edad , Preescolar , Estudios de Cohortes , Femenino , Humanos , Fórmulas Infantiles/administración & dosificación , Recién Nacido , Pruebas de Inteligencia , Masculino , Estudios Prospectivos , Factores Sexuales , Deficiencia de Tiamina/inducido químicamente
19.
Nicotine Tob Res ; 15(2): 562-6, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-22923603

RESUMEN

INTRODUCTION: Ultra-orthodox Jews compose a segregated group that struggles to preserve its centuries-old way of life by strictly adhering to the Jewish religious law in every aspect of life. Their health habits were infrequently studied to date. We sought to determine the smoking prevalence and to find its significant correlates in the ultra-orthodox Jewish population of Israel. METHODS: The study was conducted in a cross-sectional design of men as smoking prevalence among ultra-religious women was found to be negligible in previous studies. Following a random ultra-orthodox households sampling and a phone survey, a total of 782 adult men were recruited. RESULTS: The age-adjusted smoking prevalence was 12.8% (95% confidence interval [CI] = 10.3%-15.3%). The multivariate model demonstrated that being single (odds ratio [OR] = 5.83; 95% CI = 2.44-13.98), being of Israeli (OR = 2.10; 95% CI = 1.18-3.71), or North African/Asian origin (OR = 2.92; 95% CI = 1.55-5.53) was positively correlated with smoking while being a full-time Yeshiva student (OR = 0.51; 95% CI = 0.30-0.85) was negatively correlated with smoking. CONCLUSION: The Israeli ultra-orthodox Jewish men have very low prevalence of smoking when compared with the general population. The study contributes to a better understanding of habitual smoking correlates in ultra-religious minorities.


Asunto(s)
Judíos , Nicotiana , Fumar/epidemiología , Adulto , Estudios Transversales , Humanos , Israel/epidemiología , Masculino , Análisis Multivariante , Prevalencia
20.
Dermatology ; 226(3): 195-9, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23711459

RESUMEN

BACKGROUND: Tobacco smoking and exposure to environmental tobacco smoke (ETS) are known risk factors for asthma, but their association with atopic eczema is unclear. OBJECTIVE: To investigate the association of smoking and exposure to ETS with prevalence of atopic eczema in a national sample of 13- to 14-year-olds in Israel. METHODS: Cross-sectional study within the framework of the International Study on Asthma and Allergies in Childhood. RESULTS: Complete data were available for 10,298 schoolchildren. Atopic eczema as well as asthma and allergic rhinitis were significantly more prevalent in smokers than nonsmokers. Multiple regression analysis revealed a dose-response association between smoking and atopic eczema compared to not smoking: occasional smokers, odds ratio (OR) = 1.6 (95% confidence interval (CI) = 1.2-2.3); daily smokers, OR = 2.2 (95% CI = 1.4-3.6). Exposure to ETS at home was significantly associated with asthma (OR = 1.25; 95% CI = 1.1-1.5) but not atopic eczema. CONCLUSIONS: The dose-response association between active smoking and atopic eczema in adolescents is a novel observation which deserves further consideration.


Asunto(s)
Dermatitis Atópica/epidemiología , Fumar/epidemiología , Contaminación por Humo de Tabaco , Adolescente , Asma/epidemiología , Estudios Transversales , Femenino , Humanos , Israel/epidemiología , Masculino , Prevalencia , Rinitis Alérgica Estacional/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA